Thus, it may be possible that beta cells can be coerced to naturally release EVs containing autoantigens and PD-L1 during early stages of T1D, which could be an alternative strategy for generating tolerogenic EVs for use in a T1D setting. This evidence concerns the gene CD274 and type 1 diabetes mellitus.